Literature DB >> 8566878

Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.

P Mazza1, R Giua, S De Marco, M G Bonetti, B Amurri, C Masi, G Lazzari, C Rizzo, M Cervellera, A Peluso.   

Abstract

BACKGROUND: Iron overload in patients with thalassemia is a common feature which requires continuous chelation therapy and monitoring. Serum ferritin determination is widely accepted as a simple method for following iron load in patients with primary hemochromatosis; however, several reports on thalassemic patients emphasize that ferritinemia is not accurate and that other methods such as direct measurement of iron in the liver (HIC) and magnetic resonance imaging (MRI) are more precise.
MATERIALS AND METHODS: In order to contribute to the general understanding of iron load in thalassemia we used liver MRI to study 33 thalassemic patients, most of whom were also evaluated for iron content by liver biopsy. The data were then compared with serum ferritin levels.
RESULTS: Ferritin levels ranged between 276 and 8031 ng/mL, and liver iron content ranged from 1.6 to 31.0 mg/g dry weight; grade III or IV liver siderosis was recorded in 23/33 patients, just as 23/33 patients were found to have severe or very severe siderosis at MRI. Significant correlations with ferritin levels were recorded between grade IV and grades III, II and I (p < 0.01, p = 0.02, and p = 0.03, respectively). Ferritinemia also showed significant linearity with liver iron content (r = 0.603, p = 0.001). No significant differences of levels were recorded, however, between patients found to have severe and those with mild iron load at MRI (p = 0.073).
CONCLUSIONS: Our study shows that serum ferritin levels exhibit a tendency to be significantly correlated with the true status of hemochromatosis in thalassemic patients; however, the discrepancies recorded in several patients and the scarce or total lack of correlation with MRI suggest exploring other approaches to this problem in order to make proper decisions about therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566878

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  19 in total

1.  T2* magnetic resonance imaging of the liver in thalassemic patients in Iran.

Authors:  Farhad Zamani; Sara Razmjou; Shahram Akhlaghpoor; Seyyedeh-Masoomeh Eslami; Azita Azarkeivan; Afsaneh Amiri
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Retrospective comparison of gradient recalled echo R2* and spin-echo R2 magnetic resonance analysis methods for estimating liver iron content in children and adolescents.

Authors:  Suraj D Serai; Robert J Fleck; Charles T Quinn; Bin Zhang; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2015-05-26

3.  Evaluation of Iron Overload in the Heart and Liver Tissue by Magnetic Resonance Imaging and its Relation to Serum Ferritin and Hepcidin Concentrations in Patients with Thalassemia Syndromes.

Authors:  Volkan Karakus; Ayşegül Kurtoğlu; Dilek Ersil Soysal; Yelda Dere; Selen Bozkurt; Erdal Kurtoğlu
Journal:  Indian J Hematol Blood Transfus       Date:  2016-10-07       Impact factor: 0.900

4.  Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications.

Authors:  Tzu-Yao Chuang; Ju-Pi Li; Te-Fu Weng; Kang-Hsi Wu; Yu-Hua Chao
Journal:  Ann Hematol       Date:  2020-07-31       Impact factor: 3.673

5.  Effect of deferasirox chelation on liver iron and total body iron concentration.

Authors:  Javed Ahmed; Noor Ahmad; Bhavin Jankharia; Pradeep Krishnan; Rashid H Merchant
Journal:  Indian J Pediatr       Date:  2013-05-29       Impact factor: 1.967

Review 6.  Iron chelation therapy in the management of thalassemia: the Asian perspectives.

Authors:  Vip Viprakasit; Chan Lee-Lee; Quah Thuan Chong; Kai-Hsin Lin; Archrob Khuhapinant
Journal:  Int J Hematol       Date:  2009-10-29       Impact factor: 2.490

7.  Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.

Authors:  Thomas V Adamkiewicz; Miguel R Abboud; Carole Paley; Nancy Olivieri; Melanie Kirby-Allen; Elliott Vichinsky; James F Casella; Ofelia A Alvarez; Julio C Barredo; Margaret T Lee; Rathi V Iyer; Abdullah Kutlar; Kathleen M McKie; Virgil McKie; Nadine Odo; Beatrice Gee; Janet L Kwiatkowski; Gerald M Woods; Thomas Coates; Winfred Wang; Robert J Adams
Journal:  Blood       Date:  2009-08-31       Impact factor: 22.113

8.  Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores.

Authors:  Eleni E Drakonaki; Thomas G Maris; Alex Papadakis; Apostolos H Karantanas
Journal:  Eur Radiol       Date:  2006-12-16       Impact factor: 7.034

9.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

Review 10.  MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.

Authors:  Maria I Argyropoulou; Loukas Astrakas
Journal:  Pediatr Radiol       Date:  2007-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.